Drug Shortage Report for VINORELBINE TARTRATE FOR INJECTION
Report ID | 17779 |
Drug Identification Number | 02271214 |
Brand name | VINORELBINE TARTRATE FOR INJECTION |
Common or Proper name | VINORELBINE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | VINORELBINE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5ML |
ATC code | L01CA |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2017-07-30 |
Estimated end date | 2018-04-30 |
Actual end date | 2018-05-01 |
Shortage status | Resolved |
Updated date | 2018-05-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2018-05-08 | French | Compare |
v7 | 2018-05-08 | English | Compare |
v6 | 2018-03-20 | French | Compare |
v5 | 2018-03-20 | English | Compare |
v4 | 2017-12-19 | English | Compare |
v3 | 2017-08-01 | French | Compare |
v2 | 2017-08-01 | English | Compare |
v1 | 2017-08-01 | English | Compare |
Showing 1 to 8 of 8